Your browser doesn't support javascript.
loading
Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy.
Lee, Hansol; Ferguson, Angela L; Quek, Camelia; Vergara, Ismael A; Pires daSilva, Ines; Allen, Ruth; Gide, Tuba Nur; Conway, Jordan W; Koufariotis, Lambros T; Hayward, Nicholas K; Waddell, Nicola; Carlino, Matteo S; Menzies, Alexander M; Saw, Robyn P M; Shklovskaya, Elena; Rizos, Helen; Lo, Serigne; Scolyer, Richard A; Long, Georgina V; Palendira, Umaimainthan; Wilmott, James S.
Afiliación
  • Lee H; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Ferguson AL; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Quek C; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
  • Vergara IA; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Pires daSilva I; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
  • Allen R; Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia.
  • Gide TN; Infection, Immunity and Inflammation theme, School of Medical Sciences, The Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
  • Conway JW; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Koufariotis LT; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Hayward NK; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
  • Waddell N; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Carlino MS; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Menzies AM; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
  • Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Shklovskaya E; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Rizos H; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
  • Lo S; Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia.
  • Scolyer RA; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Long GV; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
  • Palendira U; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Wilmott JS; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Clin Cancer Res ; 29(13): 2513-2524, 2023 07 05.
Article en En | MEDLINE | ID: mdl-36790412
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Melanoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Melanoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Australia